TVRD (STOCKS)
Tvardi Therapeutics, Inc. Common Stock
$2.990000
+0.090000 (+3.10%)
Prev close: $2.900000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Imran Alibhai
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $28.52M
- Employees
- 12
- P/E (TTM)
- -0.54
- P/B (TTM)
- 1.30
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $0.00 |
| Operating Expenses | $26.75M |
| Research and Development | $18.01M |
| Other Operating Expenses | $8.74M |
| Operating Income/Loss | -$26.75M |
| Income/Loss From Continuing Operations After Tax | -$18.21M |
| Income/Loss From Continuing Operations Before Tax | -$18.21M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$18.21M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$18.21M |
| Net Income/Loss Available To Common Stockholders, Basic | -$18.21M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$2.46 |
| Diluted Earnings Per Share | -$3.26 |
| Basic Average Shares | 7,419,060 |
| Diluted Average Shares | 7,783,182 |
| Assets | $32.07M |
| Current Assets | $31.54M |
| Noncurrent Assets | $535.00K |
| Fixed Assets | $52.00K |
| Intangible Assets | $322.00K |
| Other Non-current Assets | $161.00K |
| Liabilities | $11.13M |
| Current Liabilities | $11.04M |
| Accounts Payable | $3.22M |
| Wages | $1.30M |
| Other Current Liabilities | $6.53M |
| Noncurrent Liabilities | $85.00K |
| Equity | $20.95M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $20.95M |
| Liabilities And Equity | $32.07M |
| Net Cash Flow From Operating Activities | -$23.50M |
| Net Cash Flow From Operating Activities, Continuing | -$23.50M |
| Net Cash Flow From Investing Activities | -$10.08M |
| Net Cash Flow From Investing Activities, Continuing | -$10.08M |
| Net Cash Flow From Financing Activities | $22.70M |
| Net Cash Flow From Financing Activities, Continuing | $22.70M |
| Net Cash Flow | -$10.88M |
| Net Cash Flow, Continuing | -$10.88M |
| Comprehensive Income/Loss | -$18.21M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$18.21M |
| Other Comprehensive Income/Loss | $8.00K |